Electroceutical Targeting of the Autonomic Nervous System

Physiology (Bethesda). 2019 Mar 1;34(2):150-162. doi: 10.1152/physiol.00030.2018.

Abstract

Autonomic nerves are attractive targets for medical therapies using electroceutical devices because of the potential for selective control and few side effects. These devices use novel materials, electrode configurations, stimulation patterns, and closed-loop control to treat heart failure, hypertension, gastrointestinal and bladder diseases, obesity/diabetes, and inflammatory disorders. Critical to progress is a mechanistic understanding of multi-level controls of target organs, disease adaptation, and impact of neuromodulation to restore organ function.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autonomic Nervous System / physiopathology*
  • Diabetes Mellitus / physiopathology
  • Diabetes Mellitus / therapy
  • Electric Stimulation Therapy / instrumentation
  • Electric Stimulation Therapy / methods*
  • Gastrointestinal Diseases / physiopathology
  • Gastrointestinal Diseases / therapy
  • Heart Diseases / physiopathology
  • Heart Diseases / therapy*
  • Humans
  • Inflammation / physiopathology
  • Inflammation / therapy
  • Obesity / physiopathology
  • Obesity / therapy
  • Spinal Cord Stimulation / instrumentation
  • Spinal Cord Stimulation / methods
  • Urinary Bladder Diseases / physiopathology
  • Urinary Bladder Diseases / therapy
  • Vagus Nerve Stimulation / instrumentation
  • Vagus Nerve Stimulation / methods